Secure your early-bird registration to Australia’s premier life sciences event, AusBiotech 2023, before 18 September, save up to $350, and join the industry in celebrating Australia’s biggest week in biotech.
The AusBiotech 2023 national conference, hosted in Brisbane from 1-3 November, will feature over 50 engaging sessions and more than 120 speakers, highlighting Australia’s role in advancing biotechnology on the world stage.
The largest life sciences event in Australia provides access to:
- Three days of programme sessions featuring an impressive lineup of 120+ expert speakers;
- Our industry partners - connect in the exhibition hall;
- AusPartnering, AusBiotech's highly popular business matching programme, facilitates thousands of 1:1 meetings across the conference week;
- Networking opportunities with other delegates and partners;
- The AgriBiotech Summit – a one-day agri-bio-focused summit held onsite at AusBiotech 2023;
- The Early-Stage Innovation Forum – discover emerging technologies at our rapid-fire pitch competition for researchers and pre-seed companies;
- Lunch, morning and afternoon refreshments in the exhibition hall; and,
- Social highlight of the week – the AusBiotech 2023 conference dinner.
The AusBiotech 2023 programme features a broad array of Australian and global industry leaders, including company CEOs, investors, policymakers, intellectual property experts, and service providers.
Providing an invaluable opportunity to hear from heads of pharma search, evaluation and venture investment leads on challenges and trends facing both global and medium-sized pharmaceutical companies on the global stage, panellists include: Dr Jessica Droge, VP External R&D, Amgen; Dr Michelle Booden, Director Business Development and Licensing, MSD; Dr Frank DeRosa, Chief Technology Officer and Global Head of Research, mRNA Centre of Excellence, Sanofi; Dr Donmienne Leung, Director, AbbVie Ventures; and Dr Richard Woodfield, Country Medical Director, Roche.
Keynote Dr Sam Costello, Chief Executive Officer and Co-Founder of BiomeBank, the inventor of BIOMICTRA, will present 'First-in-class donor-derived microbiome therapy informing drug discovery' to share how BiomeBank is using BIOMICTRA in other diseases to inform drug discovery of second-generation cultured microbiome-based therapies.
AusBiotech 2023’s Millis Orator Emeritus Professor Ian Frazer, The University of Queensland; Director, Microba, will address 'Navigating the future: Predictions and potential of Australian biotechnology'. The Millis Oration is named in honour of Emeritus Professor Nancy Millis's contribution to the industry and is held annually at the AusBiotech conference together with continuous support from CSL.
Keynote Dr Lisa Haile, Partner, DLA Piper, will be joined by Prof. Nick Opie, CIO, Synchron, to present on Dancing with patents, where they’ll navigate the US regulatory environment and the consequences and risks of not surveying the patent landscape well in advance, using others’ data within your own patent applications and tips on how to manage your company’s IP risks as part of your overall business strategy.
Keynote Dr Francis Gurry, Strategic Director, IPH Group and Ex-Director General at World Intellectual Property Organisation (WIPO), will shed light on the trends that are shaping IP strategy internationally and how these may have a significant impact on your organisation’s ability to protect inventions, attract investment, and grow the business locally and abroad in his keynote Global IP Trends.
AusBiotech 2023 is created by industry, for industry, and for almost four decades, it has created a forum to reflect on and celebrate the sector’s achievements and exchange ideas to advance the industry further. The Queensland Government proudly sponsors the 2023 national conference.
Join AusBiotech 2023 in person to celebrate and connect with our thriving Australian ecosystem by registering here.